Based on PubMed | Can persistent dizziness be a symptom of endometrial cancer, and what mechanisms or related complications could cause it?

Persistent dizziness is not a classic hallmark of endometrial (uterine) cancer itself, but it can occur from several cancer‑related complications or from treatments. Common pathways include anemia from bleeding, dehydration, treatment side effects, infection or immune‑related issues, and blood clots affecting the lungs or brain. ^{[1] [2] [3]}

Key takeaway

• Endometrial cancer most often presents with abnormal uterine bleeding, not dizziness. However, dizziness can arise secondarily from anemia due to blood loss, treatment toxicities (for example from chemotherapy or immunotherapy), dehydration, infections, and thromboembolic events. ^{[1] [2] [3]}

---

When endometrial cancer itself leads to dizziness

• Anemia from abnormal uterine bleeding: Endometrial cancer frequently causes abnormal bleeding; ongoing blood loss can lower red blood cells and hemoglobin, leading to reduced oxygen delivery and dizziness or light‑headedness. Anemia is a recognized complication and can present with dizziness and fatigue. ^{[1] [2] [3]}

• Advanced or metastatic disease: In later stages, overall illness burden, poor oral intake, and deconditioning may contribute to light‑headedness and orthostatic symptoms. Additionally, some neurological paraneoplastic syndromes are rare but reported with gynecologic cancers and could affect balance, though these are uncommon. ^{[4] [5]}

---

Treatment‑related causes of dizziness

• Chemotherapy‑associated anemia and dehydration: Platinum and taxane‑based regimens commonly used for endometrial cancer can cause or worsen anemia, which often presents with dizziness and pallor. Patient guidance for carboplatin/paclitaxel highlights dizziness or light‑headedness as signs of low red blood cells. ^{[2] [6] [7]} Diarrhea, nausea, or poor intake during therapy can cause dehydration, which also triggers dizziness. ^[2]

• Combination regimens with immunotherapy: When carboplatin/paclitaxel is combined with checkpoint inhibitors (durvalumab or dostarlimab), guidance notes dizziness in the context of anemia and also warns that some immune‑related neurologic or endocrine adverse events can cause dizziness or drowsiness. New headaches, fever, stiff neck, confusion, or pronounced drowsiness with dizziness may signal serious immune‑related conditions and require urgent assessment. ^{[8] [9] [6] [7]}

• Hormonal therapy: Progestins (for recurrent disease) include patient information that specifically mentions dizziness or feeling light‑headed, sometimes related to treatment effects or dehydration, with practical advice to hydrate and rise slowly from sitting. ^{[10] [11]}

• Other cytotoxic regimens: Doxorubicin/cisplatin regimens list dizziness or light‑headedness associated with anemia among expected effects, again reinforcing the anemia pathway. ^{[3] [12]}

---

Thromboembolic events (blood clots)

• Deep vein thrombosis (DVT) and pulmonary embolism (PE): Gynecologic cancers, including endometrial cancer, carry a higher risk of venous thromboembolism (VTE). Silent DVT and even PE can be present before treatment in a notable minority of endometrial cancer cases, with risk linked to extra‑uterine spread and certain histologies. ^{[13] [14]} PE can cause light‑headedness, shortness of breath, chest discomfort, and fainting, and requires urgent care. ^[4]

---

Infections and sepsis risk

• Chemotherapy‑related neutropenia can predispose to infections, which may present with fever, malaise, and low blood pressure leading to dizziness or faintness; educational materials emphasize seeking immediate help for concerning symptoms. Dizziness with fever or new neurological signs during immunotherapy warrants urgent evaluation. ^{[8] [9]}

---

Practical approach if dizziness persists

• Assess for anemia: A complete blood count can identify low hemoglobin; educational materials consistently link dizziness with low red blood cells during common endometrial cancer treatments. ^{[2] [6] [7] [3]}

• Check hydration and electrolytes: Treatment side effects like diarrhea and poor intake are common; dehydration is a recognized cause of dizziness in patients receiving hormonal therapy and chemotherapy. ^{[11] [2]}

• Screen for thromboembolism if symptoms suggestive: Unexplained light‑headedness with shortness of breath, chest pain, or rapid heart rate should prompt evaluation for PE, especially in the setting of cancer; silent VTE is not rare in endometrial cancer before therapy. ^{[13] [14]}

• Consider immune‑related or neurologic causes on immunotherapy: Dizziness with headache, confusion, neck stiffness, or new weakness requires urgent assessment for immune‑mediated neurologic or endocrine events. ^{[8] [9]}

• Monitor for infection: Fever with dizziness can indicate sepsis risk during chemotherapy or immunotherapy and needs immediate care. Patient instructions highlight urgent reporting of these red flags. ^{[8] [9] [2]}

---

Summary table: Why dizziness can occur in endometrial cancer

• Cause: Anemia from bleeding or treatment

  • How it causes dizziness: Reduced oxygen to the brain leads to light‑headedness, fatigue, pallor
  • What to do: CBC, manage bleeding, transfusion/iron as appropriate
  • Sources: ^{[1] [2] [6] [7] [3]}

• Cause: Dehydration/electrolyte loss

  • How it causes dizziness: Low blood volume and orthostatic symptoms
  • What to do: Rehydrate, correct electrolytes, manage diarrhea/nausea
  • Sources: ^{[11] [2]}

• Cause: Treatment toxicities (chemo, immunotherapy, hormones)

  • How it causes dizziness: Anemia, neurologic/endocrine adverse events, general side effects
  • What to do: Report symptoms promptly; consider dose adjustments and workup for immune‑related events
  • Sources: ^{[2] [6] [7] [8] [9] [10]}

• Cause: Thromboembolic events (DVT/PE)

  • How it causes dizziness: PE reduces oxygenation and cardiac output; can cause syncope
  • What to do: Urgent evaluation for VTE; anticoagulation if confirmed
  • Sources: ^{[13] [14] [4]}

• Cause: Infection/sepsis during therapy

  • How it causes dizziness: Low blood pressure and systemic illness
  • What to do: Urgent assessment and antibiotics as needed
  • Sources: ^{[8] [9]}

• Cause: Rare paraneoplastic neurologic syndromes

  • How it causes dizziness: Cerebellar or brainstem involvement can affect balance
  • What to do: Neurologic evaluation and paraneoplastic workup
  • Sources: ^{[5] [4]}

---

Bottom line

Persistent dizziness is not a typical first sign of endometrial cancer, but it can reasonably occur due to anemia, dehydration, treatment side effects (including immune‑related events), infections, or blood clots, and these possibilities should be evaluated systematically. Because some causes like pulmonary embolism or immune‑related neurologic problems can be serious, new or worsening dizziness, especially with shortness of breath, chest pain, fever, severe headache, confusion, or fainting, should prompt urgent medical attention. ^{[1] [2] [8] [9] [13] [14]}